Interactions with Monoamine Oxidase Inhibitors
SIR,-This company receives almost weekly a nunmber of inquiries on the possible hazards to patients and adverse effects of taking certain foodstuffs, drinks, and other drugs while on phenelzine. Despite considerable efforts on our part to disseminate factual information on these aspects of monoamine oxidase inhibitor (MAOI) therapy we are becoming increasingly concerned, as these inquiries show a repeated and continuing niisunderstanding of the problem. It would appear that many doctors in general practice and psychiatrists in hospital who actually start a patient on a MAOI drugs have an incomplete appreciation and at times erroneous knowledge of interactions. Their misunderstanding in many instances appears to be based on rather tenuous evidence from a single reported adverse reaction. This interaction is then perpetuated in the literature by succeeding authors who rarely take the trouble to read the original report or substantiate the reaction. In this way the reported interaction acquires unwarranted and unrealistic importance. Screening for Breast Cancer SIR,-Though a member of the British Breast Group, I asked that my name should not be included among the signatories to the published statement concerning screening for breast cancer (9 August, p. 357). In their statement the members of the group affirmed that they are "convinced that the early diagnosis of breast cancer is important and that it improves the cure rate." I too subscribe to this conviction and, having been involved in the West London pilot study since its inception, I am now also convinced of the reliability of determined mammary screening in the detection of early cancer. Despite all the expected administrative, financial, and staffing difficulties I should like to see a resolute effort made now to establish a national screening service. I had hoped that the British Breast Group would give its co-operative and authoritative blessing to this concept, but that was not to be. A great opportunity may have been lost. I had accepted that the published statement represented the views of the majority of my colleagues in the group, however, and it was not this that has prompted my reply. Granny-battering SIR,-Hardly a week goes by without some reference in the national press or medical journals to baby-battering, and I think it is about time that all of us realized that elderly people too are at times deliberately battered. I have personal knowledge of cases in which it has been possible to confirm that elderly patient3 have been battered by relatives before admission to hospital and in which there has been no doubt that the battering was deliberate. In other cases assault at home has been suspected but could not be confirmed. This leads one to wonder how many of the elderly who "fall down frequently, doctor" do so because they are assaulted.
Often the type of patient in whom the suspicion of battering must be very high has some mental impairment. While in no wav condoning the battering of elderly people by their relatives, I am certain it is just another manifestation of the inadequate care we as a profession give to elderlv people and to their relatives who are left with the task of coping with them unaided and unsupported by us. It is hardly surprising under these circumstances that the battering becomes almost a natural consequence of the inadequate service. Perhaps gencral practitioners in particular and casualty officers espccially should become as conscious of grannybattering av they are now awarc of babvbattering. Communitv nurses, health visitors, and social workers should also have this aspect of "caring for the elderly" drawn to their attention. The Aflatoxin-Hepatoma-HBAg Story SIR,-"More on the Aflatoxin-Hepatoma Story" you entitle your leading article (21 June, p. 647): but there is more yet. It aflatoxin (AF) is the paradigm, it is but the tip of the mycohepatotoxin iceberg,' which includes other aspergillus metabolites like ochratoxin and sterygmatocystin and their penicillium equivalents, luteoskyrin and others, to name but two mould genera commonly found contaminating stored crops. Nor do you mention other plant hepatotoxins such as pyrrolizidine alkaloids (PA), though one of the papers you quote2 has shown these to be synergistic with AF in producing cirrhosis and hepatoma in primates. Best known as the putative cause of "bush-tea"-induced veno-occlusive disease, these occur throughout the world in disparate genera,3 sometimes contaminating grain-for example, senecios in South Africa' and Iraq,' heliotropiums in Central Asia,6 or even as potherbs, as with the leguminous crotalarias of East Africa.7 The single-dose interval induction of rat hepatoma by AF that you mention is even more impressive with PA,9 even delivered via the milk of a nursing mother;9 for which reason Schoental'0 has suggested examination of traditional herbal "medicines" for pregnancy, parturition, or the newborn.
You mention hepatitis B (HB) antigenaemia accompanying hepatoma yet fail to refer to the extrahepatic component of this state-ramely, the defective immune response it bespeaks. This may be due to insult with the same toxin which acts directly on the hepatocyte, simultaneously perhaps with colonization with a virus (HB) not itself cytopathogenic but becoming so only indirectly, by evoking a cell-mediated immune response'" or, in default of this response, producing the persisting antigenaemia you refer to. But AF itself is immunosuppressive," " as to a lesser extent are ochratoxin and sterygmatocystin, while the fusarial toxin T2'1 is even more so," halting phytohaemagglutinin-induced lymphlocyte transformation in dilutions as low as 1 ,ug/l or less. Furthermore, lymphocyte abnormalities have been noted in the wakc of venoocclusive disease, both human and experimental.'6 And hepatoma, once established, may be as lymphocvte-inhibitorv as other cancers.' HB antigenaemia has been reported
